Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
JAMA Oncology
|
September 23, 2018
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
Daniel Y Wang, Joe-Elie Salem, Justine V Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2026
Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update
Alice P Chen, Christina L Rosenberger, Nancy Moore, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 16, 2022
Correction to: Machine learning for rhabdomyosarcoma histopathology
Arthur O Frankel, Melvin Lathara, Celine Y Shaw, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 22, 2022
Machine learning for rhabdomyosarcoma histopathology
Arthur O Frankel, Melvin Lathara, Celine Y Shaw, et al.
Cancer
|
October 29, 2025
Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938)
Liza C Villaruz, Jingxiao Jin, Hong Wang, et al.
The New England Journal of Medicine
|
September 6, 2023
Atezolizumab for Advanced Alveolar Soft Part Sarcoma
Alice P Chen, Elad Sharon, Geraldine O'Sullivan-Coyne, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 11, 2026
NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025
Margaret von Mehren, John M Kane, Samantha A Armstrong, et al.
Cancers
|
September 9, 2022
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study
Michael J Wagner, Cassandra Hennessy, Alicia Beeghly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 8, 2022
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial
Mrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah, et al.
Cancer Treatment Reviews
|
August 28, 2022
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments
Silvia Stacchiotti, Anna Maria Frezza, George D Demetri, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
JAMA Oncology
|
September 23, 2018
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
Daniel Y Wang, Joe-Elie Salem, Justine V Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2026
Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update
Alice P Chen, Christina L Rosenberger, Nancy Moore, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 16, 2022
Correction to: Machine learning for rhabdomyosarcoma histopathology
Arthur O Frankel, Melvin Lathara, Celine Y Shaw, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 22, 2022
Machine learning for rhabdomyosarcoma histopathology
Arthur O Frankel, Melvin Lathara, Celine Y Shaw, et al.
Cancer
|
October 29, 2025
Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938)
Liza C Villaruz, Jingxiao Jin, Hong Wang, et al.
The New England Journal of Medicine
|
September 6, 2023
Atezolizumab for Advanced Alveolar Soft Part Sarcoma
Alice P Chen, Elad Sharon, Geraldine O'Sullivan-Coyne, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 11, 2026
NCCN Guidelines® Insights: Soft Tissue Sarcoma, Version 1.2025
Margaret von Mehren, John M Kane, Samantha A Armstrong, et al.
Cancers
|
September 9, 2022
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study
Michael J Wagner, Cassandra Hennessy, Alicia Beeghly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 8, 2022
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial
Mrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah, et al.
Cancer Treatment Reviews
|
August 28, 2022
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments
Silvia Stacchiotti, Anna Maria Frezza, George D Demetri, et al.
Page
of 5